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Abstract
Introduction: Vitamin D was shown to be related to endothelial function and blood
pressure. Reactive hyperaemia index (RHI) measurement by pulse arterial tonom-
etry is a new method to evaluate vasodilator function of endothelium. We aimed
to evaluate the relationship between vitamin D levels and RHI in women.
Material and methods: We enrolled 56 normotensive, nonsmoker, normolipi-
demic and normoglycemic women, (23 with 25-OH-vita  min D levels > 20 μg/l,
and 33 with values lower than 20 μg/l). The cardiologist who was blind for vita-
min D results executed measurements by pulse arterial tonometry. The meas-
urement was performed on the lying patient with pre- and post-occlusion meas-
urements of RHI by digital sensors placed on each index finger, by 5 min
intervals. Pulse amplitudes were recorded, pre-occlusion and post-occlusion
ratio was compared by the software of device. Stepwise linear regression and
multiple regression analyses were performed to evaluate predictors of endothe-
lial function.
Results: The low vitamin D group had a lower RHI value than the normal vita-
min D group (p = 0.042). In regression analysis, positive predictors of RHI were
serum 25-OHD (β = 0.401; 95% CI 0.010-0.042, p = 0.002), serum albumin 
(β = 0.315; 95% CI 0.286-2.350, p = 0.013), and, inversely, serum calcium 
(β = –0.247; 95% CI (–1.347)-(–0.010), p = 0.047). 
Conclusions: Serum 25-hydroxy vitamin D was significantly related to endothe-
lial functions measured as RHI, even in healthy non-smoker women. 
Key words: vitamin D, tonometry, endothelium, endothelial function, reactive hyper-
aemia index.
Introduction
Recently, a large body of evidence has highlighted the role of vitamin D
in different physiopathological settings other than bone and calcium,
including endothelial functions and blood pressure [1, 2]. In fact, cross-sec-
tional analyses and prospective studies revealed that 25-hydroxy vitamin D
(25-OHD) serum levels were inversely related to high cardiovascular risk
[3-5] and calcium metabolism and the cardiovascular system may have an
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interaction [6]. On the other hand, normalisation of
25-OHD level by exogenous supplementation is
associated with a slight but significant improve-
ment in blood pressure [7-10]. 
Beyond all this evidence, the final explanation
of the vitamin D antihypertensive effect is yet not
fully understood [1]. Since vitamin D receptors are
expressed in many tissues, it may have an effect
on inflammation, cell proliferation and differentia-
tion [11], all factors that could influence vascular
function and health. Preclinical studies and clinical
reports showed an inverse association of vitamin D
and endothelial function [12, 13]. Very recently, Har-
ris et al. observed in a small group of African-Amer-
ican overweight patients that vitamin D3 supple-
mentation may improve flow-mediated dilatation
when compared to placebo [14]. 
The relationship between vitamin D and endo  -
thelial dysfunction is still not clear. Studies with
non-invasive methods to measure endothelial func-
tion generally use FMD (flow-mediated dilatation)
of large arteries, asymmetric dimethyl arginine
measurements or augmentation index calculations
from pulse wave velocity [12, 15, 16]. 
Reactive hyperaemia index (RHI) measurements
taken with a pulse amplitude tonometry (PAT)
device were found to be correlated with adverse
cardiac events in different studies [17, 18], but there
has not been any study examining the relationship
between vitamin D levels and RHI measurements
with this tonometric method.
In this context, the aim of our study was to eval-
uate the relationship between endothelial function
and vitamin D serum level in a cohort of nor-
motensive, non-smoker, normolipidaemic and nor-
moglycaemic women, evaluated by the tonometric
measurement of the RHI.
Material and methods
Patients
For this study, we consecutively enrolled 56 nor-
motensive, non-smoker, normolipidaemic and 
normoglycaemic women, 23 with 25-OHD levels 
> 20 μg/l (normal range) and 33 with values lower
than 20 μg/l (low 25-OHD group) [19]. Patients
using vitamin or calcium preparations, or affected
by known osteoporosis, renal or hepatic disease
were excluded from the study.
Anthropometric parameters were recorded and
body mass index (BMI) was calculated as weight
in kilograms divided by square of height in metres
(kg/m2). Blood pressure was measured by stan-
dard sphygmomanometer and recorded from
both arms while the patients were in a sitting
position. According to the current guidelines [20]
the measurements were repeated 3 times with
minimum 5-min intervals and the mean value was
recorded. 
Informed consent was obtained from each
patient, and the study protocol conforms to the eth-
ical guidelines of the 1975 Declaration of Helsinki
as reflected in a priori approval by the university’s
Human Research Committee.
Endothelial function measurement
Pulse amplitude tonometry (PAT) is a technique
for non-invasive endothelial function assessment
from changes in vascular tone using plethysmo-
graphic bio-sensors placed on the fingertips. [21]. It
is based on non-invasive peripheral arterial tone
signal technology. Standard 5-min occlusion of the
brachial artery by a cuff creates a downstream
hyperaemic response and changes in arterial tone
are measured and the index is calculated auto-
matically by the software of the device. A RHI score
of 1.67 and below correlates with endothelial dys-
function [22].
In our study, digital pulse amplitude was meas-
ured by Endo-PAT 2000™ (Itamar, Endothelial Func-
tion Assessment Device, Caeserea, Israel) used with
the EndoPAT software system. A cardiologist who
was blind to vitamin D results made the measure-
ments. The test took nearly 15-20 min and was per-
formed in a calm and quiet room at 22°C temper-
ature, at rest. Each patient received an explanation
about the procedure before the test and gave
informed consent for the study. The measurement
was performed on the lying patient with pre- and
post-occlusion measurements of RHI by digital sen-
sors placed on each index finger, at 5-min intervals.
Inflation pressure of the device was set 10 mmHg
lower than diastolic pressure or 70 mmHg as max-
imum. Pre-occlusion baseline measurements were
made from each fingertip for 2 min and 10 s. Occlu-
sion measurements were performed by the help of
a cuff placed on the forearm with 200 mmHg or 
60 mmHg higher than the systolic blood pressure
of the patient. Pulse amplitudes were recorded, and
pre-occlusion and post-occlusion ratios were com-
pared by the software of the device, in an operator
or interpreter independent way. Average pulse
amplitudes for each 30 s were provided by the
device software. A RHI and heart rate variability
measurements were noted for each patient.
Biochemical test
Venous blood samples were obtained early in
the morning after 12-h fasting. The following
parameters were evaluated: fasting blood glucose,
total cholesterol, high-density lipoprotein (HDL) cho-
lesterol, low-density lipoprotein (LDL) cholesterol,
triglyceride, calcium, phosphorus, ionized calcium,
and parathyroid hormone (PTH) levels. Parathyroid
hormone levels were measured by electrochemilu-
minescence immunoassay (ECLIA) by an ElecsysArch Med Sci 1, February / 2012 49
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2010 analyser with inter-assay coefficient of varia-
tion below or equal to 6.5%. Thyroid-stimulating
hormone (TSH) was measured by electrochemilu-
minescence immunoassay (ECLIA) using Immulite
2000 (Diagnostic Products Corp, Los Angeles, CA,
USA) and Abbot Architect 2000. Fasting blood glu-
cose, total cholesterol, HDL cholesterol, LDL cho-
lesterol, triglyceride, calcium, phosphorus, and ion-
ized calcium measurements were made using an
automatic colorimetric method by Cobas Integra
400 Analyzer. 25-OHD measurements were made
using high performance liquid chromatography
(HPLC). ALT and AST were measured by automatic
colorimetric assay by Cobas Integra 400 Analyzer.
All measurements were standardized and per-
formed in central laboratories of Ufuk University
Medical Faculty Biochemistry Department. 
Statistical analysis
A specific database was created containing all
the available variables. Full descriptive statistics
were calculated for each parameter. Normality dis-
tribution of continuous variables was tested by the
Kolmogorov-Smirnov test. Comparisons between
groups were carried out by the application of the
Student t-test for unpaired samples or by the
Mann-Whitney U-test. A stepwise linear regression
was performed to evaluate the predictor of
endothelial function. Stepwise multiple regression
analysis was performed to determine the best pre-
dictors of RHI among the studied parameters. 
A p level less than 0.05 was considered as sta-
tistically significant. All statistics were calculated
with the help of the SPSS 15.0 (for MS Windows)
statistical software.
Results
The mean ± SD of the studied parameters is
reported in Table I. Comparing subjects with low or
normal serum vitamin D level, we observed that the
group with low vitamin D also had significantly low-
er RHI (p = 0.042).
Although calcium, ionized calcium and/or phos-
phorus levels did not show any significant differ-
Variables All patients† (n = 56) Normal 25OHD (n = 23) Low 25-OHD (n = 33) Value of p
Age [years] 41.4 ±8.6 43.0 ±8.2 40.27 ±8.7 0.245
BMI [kg/m2] 26.0 ±4.2 26.4 ±4.1 25.7 ±4.2 0.562
SBP [mmHg] 118.7 ±9.4 119.9 ±7.6 117.8 ±10.4 0.428
DBP [mmHg] 69.0 ±6.9 72.6 ±5.9 66.4 ±6.5 0.001
HR 78.79 ±9.29 78.83 ±9.80 78.76 ±9.08 0.979
Glucose [mg/dl] 91.82 ±9.67 93.79 ±12.48 90.44 ±7.00 0.978
Haemoglobin [g/dl] 13.13 ±0.93 13.03 ±0.86 13.20 ±0.98 0.510
Creatinine [mg/dl] 0.64 ±0.09 0.64 ±0.08 0.65 ±0.10 0.722
Albumin [g/dl] 4.42 ±0.23 4.39 ±0.30 4.45 ±0.16 0.390
ALT [U/l] 17.52 ±9.23 20.26 ±11.54 15.61 ±6.76 0.063
AST [U/l] 16.77 ±7.05 17.09 ±9.85 16.55 ±4.28 0.780
TSH [mIU/ml] 1.69 ±1.17 1.84 ±0.93 1.59 ±1.32 0.450
Total cholesterol [mg/dl] 193.61 ±32.40 196.49 ±30.42 191.60 ±34.03 0.583
LDL-C [mg/dl] 116.56 ±26.81 118.49 ±26.67 115.22 ±27.23 0.658
HDL-C [mg/dl] 54.34 ±12.38 54.25 ±15.85 54.41 ±9.53 0.962
TG [mg/dl] 109.24 ±17.98 105.53 ±18.11 111.83 ±17.70 0.200
Calcium [mg/dl] 9.28 ±0.35 9.25 ±0.39 9.31 ±0.32 0.536
Ionized calcium [mmol/l] 1.09 ±0.03 1.08 ±0.035 1.10 ±0.036 0.292
Phosphorus [mg/dl] 3.42 ±0.47 3.56 ±0.51 3.33 ±0.42 0.075
25OHD [μg/l] 21.32 ±14.82 36.25 ±11.61 10.91 ±3.61 0.001
PTH [pg/ml] 49.71 ±17.80 44.16 ±14.64 53.57 ±18.97 0.051
RHI 2.29 ±0.97 2.61 ±1.11 2.01 ±0.81 0.042
BMI – body mass index, 25OHD – 25-OH vitamin D, PTH – parathormone, ALT – alanine transaminase, AST – aspartate transaminase, TSH – thy-
roid stimulating hormone, TG – triglycerides, LDL-C – low-density lipoprotein cholesterol, HDL-C – high-density lipoprotein cholesterol, SBP – sys-
tolic blood pressure, DBP – diastolic blood pressure, RHI – reactive hyperaemia index, HR – heart rate, †all parameters are given as mean ± stan-
dard deviation
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ence, there was a difference in PTH levels between
groups but it was not statistically significant. Dias-
tolic blood pressure and RHI were significantly low-
er in the low 25-OHD group than in subjects with
normal 25-OHD levels. 
The stepwise multiple regression showed that
the best RHI positive predictors were serum 25-OHD
(β = 0.026; 95% CI 0.010-0.042, p = 0.002) and
serum albumin (β = 1.318; 95% CI 0.286-2.350, 
p = 0.013), while the negative one was serum 
calcium (β = –0.678; 95% CI (–1.347)-(–0.010), 
p = 0.047) (Figure 1). 
Discussion
Since the early 1980s, the discovery of vitamin
D receptors in non-classical sites (pancreas β cells,
hair follicles, some cancer cells, etc) has opened
a new point of view on vitamin D metabolism and
its role in the body [23]. Vitamin D and related
mechanisms were well studied in chronic renal dis-
ease patients but data on normal people started to
increase recently. However, beyond some interest-
ing evidence it is not yet clear how vitamin D is
related to vascular function. Recently it has been
observed that the expression of proinflammatory
transcription factor nuclear factor κB (NFκB) was
found to be greater in vitamin D deficient middle
aged and older adults: inhibition of NFκB by oral
acetylsalicylic acid improved brachial artery flow-
mediated dilatation especially in vitamin D deficient
patients [2]. On the other hand, chronic active vita-
min D treatment could reduce the levels of reactive
oxygen radicals and the expression of cyclooxyge-
nase-1 mRNA, as well [12]. The higher incidence of
cardiovascular events in winter could also be part-
ly related to the lower vitamin D levels in this sea-
son, since low vitamin D seems to be linked to high-
er serum lipid peroxidation levels and decreased
brachial artery FMD on ultrasonographic measure-
ments [24]. 
In our study, the RHI ratio was significantly low-
er in vitamin D deficient subjects than in subjects
with normal serum vitamin D, and RHI values were
strictly predicted by the serum vitamin D levels.
Probably the absence of other risk factors such as
diabetes, kidney disease, hyperlipidaemia, hyper-
tension or smoking state has a role in RHI meas-
urements higher than endothelial dysfunction
thresholds (1.67) even in low vitamin D subjects.
The better RHI ratio in normal 25-OHD patients was
also associated with a slightly but significantly low-
er diastolic blood pressure level in this group of nor-
motensive women. Moreover, RHI was predicted by
calcium and albumin separately, but not by ionized
calcium levels. The inverse relationship between
calcium level and RHI ratio is not consistent with
the previous ex-vivo evidence obtained from
a human umbilical vein cord endothelial cell cul-
ture which revealed that lower extracellular ionized
calcium levels may change endothelial cell func-
tions negatively by decreasing nitric oxide avail-
ability and increasing inflammatory mediators [25].
The possible mechanisms of vitamin D action on
endothelial functions are not totally elucidated in
the medical literature, but the studies reveal that it
might be related to the effects of vitamin D on the
renin-angiotensin system as providing a “crosstalk”
between the heart and kidneys, effects on free rad-
ical production, inflammatory and fibrotic process-
es, carbohydrate tolerance and endothelial pro-
genitor cells [26-29].
Our study has some limitations. First of all, the
patient sample was relatively small. Also, PAT meas-
urements evaluate endothelium-dependent vasodi-
latation as a response to ischaemia, so we cannot
suggest a link between 25-OHD levels and endothe-
lium-independent vasodilatation from this study.
Meanwhile, since the study groups were all women,
it is not possible to extrapolate these results to all
people. Another restriction was the lack of com-
parison between pre- and post-menopausal
women, or according to BMI, because of the low
patient number. Additionally, the blood pressure
measurements were not 24-h ambulatory meas-
urements, which are a more reliable method to
evaluate differences in blood pressure level
between groups. Furthermore, since we did not
include male patients, among whom smoking is rel-
atively common in Turkey, that may affect the PAT
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Figure 1. Simple scatter plot of correlation between
RHI and vitamin D levels
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measurements. On the other hand, the medical lit-
erature shows that endothelial results of vitamin D
deficiency do not differ between genders [15, 16]. 
However, medical studies examining the effect
of vitamin D levels on endothelial dysfunction eval-
uated by tonometric methods are not common.
Pulse amplitude tonometry measurement requires
a device and software with digital sensors which are
not suitable for multiple use. Therefore this method
may have limited use. But the device does have the
advantage of using data from both arms and it uses
the other arm as a control for systemic vascular
changes during measurement. Moreover, previous
studies support the use of digital PAT as a measure
of peripheral vasomotor function, and nitric oxide
has been shown to be an important contributor to
augmentation in pulse amplitude measured from
the finger tip after ischaemia, supported by a blunt-
ed response in PAT in the presence of endothelial
nitric oxide synthase inhibitor [30]. 
In the study of Mheid et al. it was also shown
that vitamin D replacement may also improve
endothelial function and decreases mean arterial
blood pressure in vitamin D insufficiency [31].
Although this may suggest reversibility of endothe-
lial dysfunction in vitamin D insufficiency, some
points, such as the effect of the duration of insuf-
ficiency, extrapolation of these results to vitamin D
deficiency, dose and type of vitamin D preparation
to be used, and time to restore normal endothelial
function, are still not clear.
Infact, vitamin D may have role in some mecha-
nisms related with endothelial vasodilatation and
hypertension, which are not still very clear in med-
ical literature [32].
In conclusion, on the basis of our study, it
appears that serum 25-OHD is strongly related to
endothelial functions measured from digital pulse
amplitude hyperaemic response, even in healthy
non-smoker women without hypertension, hyper-
lipidaemia, or diabetes. Further studies are needed
to evaluate the potential importance of vitamin D
replacement on prevention or reversal of endothe-
lial dysfunction, and in both genders. 
Acknowledgments
The authors report no conflicts of interest. The
authors alone are responsible for the content and
writing of the paper. 
References
1. Pilz S, Tomaschiltz A. Role of vitamin D in arterial hyper  -
tension. Expert Rev Cardiovasc Ther 2010; 8: 1599-608. 
2. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals
DR. 25-hydroxyvitamin D deficiency is associated with
inflammation-related endothelial dysfunction in middle-
aged and older adults. Hypertension 2011; 57: 63-9.
3. Kendrick J, Targher G, Smits G, Chonchol M. 25-hydro  -
xyvitamin D deficiency is associated with cardiovascular
disease in the Third National Health and Nutrition
Examination Survey. Atherosclerosis 2009; 205: 255-60.
4.  Dobnig H, Pilz S, Sharnagl H, et al. Independent
association of low 25-hydroxyvitamin D and 1,25-dihy  -
droxyvitamin D levels with all-cause and cardiovascular
mortality. Arch Intern Med 2008; 168: 1340-9.
5. Stojanovic OI, Lazovic M, Vuceljic M. Association between
atherosclerosis and osteoporosis, the role of vitamin D.
Arch Med Sci 2011; 7: 179-88.
6. Yazici S, Yazici M, Korkmaz U, et al. Relationship between
blood pressure levels and bone mineral density in
postmenopausal Turkish women. Arch Med Sci 2011; 7:
264-70.
7. Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydro  -
xyvitamin D concentration and hypertension: a meta-
analysis. J Hypertens 2011; 29: 636-45.
8.  Wu SH, Ho SC, Zhong L. Effects of vitamin D sup  -
plementation on blood pressure. South Med J 2010; 103:
729-37.
9. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D
on blood pressure: a systemic review and meta-analysis.
J Hypertens 2009; 27: 1948-54.
10. Pittas AG, Chung M, Trikalinos T, et al. Systematic review:
vitamin D and cardiometabolic outcomes. Ann Intern Med
2010; 152: 307-14.
11. Gouni-Berthold I, Krone W, Berthold HK. Vitamin D and
cardiovascular disease. Curr Vasc Pharmacol 2009; 7: 
414-22.
12. Wong MS, Delansorne R, Man RY, Svenningsen P,
Vanhoutte PM. Chronic treatment with vitamin D lowers
arterial blood pressure and reduces endothelium-
dependent contractions in the aorta of spontaneously
hypertensive rat. Am J Physiol Heart Circ Physiol 2010;
299: H1226-34. 
13. Ngo DT, Sverdlov AL, McNeil JJ, Horowitz JD. Does vitamin
D modulate asymmetric dimethylarginine and C-reactive
protein concentrations? Am J Med 2010; 123: 335-41.
14. Harris RA, Pedersen-White J, Guo DH, et al. Vitamin D(3)
supplementation for 16 weeks improved flow-mediated
dilatation in overweight African-American adults. Am 
J Hypertension 2011; 24: 557-62.
15. Andrade J, Er L, Ignaszewski A, Levin A. Exploration of
association of 1,25-OH2D3 with augmentation index ,
a composite measure of arterial stiffness. Clin J Am Soc
Nephrol 2008; 3: 1800-6. 
16. Aktoz M, Aktoz T, Tatil E, et al. Asymmetrical dimethyl
arginine and severity of erectile dysfunction and their
impact on cardiovascular events in patients with acute
coronary syndrome. Arch Med Sci 2010; 6: 168-75.
17. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of
endothelial function by non-invasive peripheral arterial
tonometry predicts late cardiovascular adverse events.
Eur Heart J 2010; 31: 1142-8. 
18. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional
relations of digital vascular function to cardiovascular risk
factors in Framingham Heart Study. Circulation 2008; 117:
2467-74.
19. Holick F, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation,
treatment and prevention of vitamin D deficiency: an
Endocrine Society Clinical Practice Guideline. J Clin
Endocrinol Metab 2011; 96: 1911-30.
20. Chobanian AV, Bakris GL, Black HR, et al. Seventh report
of the Joint National Committee on Prevention, Detection,
Evaluation, and Treatment of High Blood Pressure.
Hypertension 2003; 42: 1206.52 Arch Med Sci 1, February / 2012
Sibel Ertek, Ebru Akgül, Arrigo F. Cicero, Utku Kütük, Selda Demirtaș, Sengül Çehreli, Gürbüz Erdog ˘an
21. Hamburg NM, Benjamin EJ. Assessment of endothelial
function using digital pulse amplitude tonometry. Trends
Cardiovascular Med 2009; 19: 6-11. 
22. Bonetti PO, Pumper GM, Higano ST, Holmes DR Jr, Kuvin
JT, Lerman A. Noninvasive identifications of patients with
early coronary atherosclerosis by assessment of digital
reactive hyperemia. J Am Coll Cardiol 2004; 44: 2137-41.
23. Norman AW. Minireview: vitamin D receptor: new
assignments for an already busy receptor. Endocrinology
2006; 147: 5542-8.
24. Tarcin O, Yavuz DG, Ozben B, et al. Effect of vitamin D
deficiency and replacement on endothelial function in
asymptomatic patients. J Clin Endocrinol Metab 2009; 94:
4023-30.
25. Talmor-Barkan Y, Rashid G, Weintal I, Green J, Bernheim J,
Benchetrit S. Low extracellular Ca2+: a mediator of
endothelial inflammation. Nephrol Dial Transplant 2009;
24: 3306-12.
26. Yiu YF, Chan YH, Yiu KH, et al. Vitamin D deficiency is
associated with depletion of circulating endothelial
progenitor cells and endothelial dysfunction in patients
with type 2 diabetes. J Clin Endocrinol Metab 2011; 98:
E830-5.
27. Rostand SG. Vitamin D, blood pressure, and African
Americans: toward a unifying hypothesis. Clin J Am Soc
Nephrol 2010; 5: 1697-703.
28. Brewer LC, Michos ED, Reis JP . Vitamin D in athero  -
sclerosis, vascular disease and endothelial dysfunction.
Curr Drug Targets 2011; 12: 54-60. 
29. Cozzolino M, Ketteler M, Zehnder D. The vitamin D
system: a crosstalk between the heart and kidney. Eur 
J Heart Fail 2010; 12: 1031-41. 
30. Nohria A, Gerhard-Herman M, Creager MA, Hurley S, Mi  -
tra D, Ganz P . Role of nitric oxide in the regulation of
digital pulse volume amplitude in humans. J Appl Physiol
2006; 101: 545-8. 
31. Al Mheid I, Patel R, Murrow J, et al. Vitamin D status is
associated with arterial stiffness and vascular dysfunction
in healthy humans. J Am Coll Cardiol 2011; 58: 186-92.
32. Ertek S, Cicero AF, Erdogan G. The relationship between
calcium metabolism, insulin-like growth factor-1 and pulse
pressure in normotensive, normolipidemic and non-
diabetic patients. Arch Med Sci 2011; 7: 776-80.